Opendata, web and dolomites

Schizo-EPICOG SIGNED

Inflammatory processes underlying cognitive deficits in schizophrenia: epigenetic mechanisms and pharmacological regulation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Schizo-EPICOG project word cloud

Explore the words cloud of the Schizo-EPICOG project. It provides you a very rough idea of what is the project "Schizo-EPICOG" about.

model    inductor    tests    antipsychotic    deficits    puberty    histone    acetylation    event    phenomenon    epigenetic    psychopathology    nuclear    vulnerability    signalling    mechanism    inmmune    controls    involvement    double    stressful    suspected    data    subjects    animal    social    excess    emerge    gestation    saha    hdac    protein    hyperactivity    behavioural    status    inhibitor    chronic    validated    patients    isolation    peripuberty    priming    prefrontal    postmortem    treatments    hdacs    human    neuroinflammatory    gene    possibility    minocycline    treatment    expression    disease    symptoms    atypical    hit    schizophrenia    proteins    cortex    preliminary    neuroinflammation    neuroinflammmatory    physio    traslational    indicate    activation    psychotic    regulation    inflammatory    induce    suggested    followed    maternal    etiopathogenesis    antipsychotics    free    prognostic    relationship    modulation    cognitive    clinically    mechanisms    prenatal    schizophrenic    matched    effect    worsen    mouse    clozapine    resistant    molecular    deacetylases    drug    alterations    markers   

Project "Schizo-EPICOG" data sheet

The following table provides information about the project.

Coordinator
UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA 

Organization address
address: BARRIO SARRIENA S N
city: LEIOA
postcode: 48940
website: www.ehu.es

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 158˙121 €
 EC max contribution 158˙121 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-04-11   to  2020-04-10

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA ES (LEIOA) coordinator 158˙121.00

Map

 Project objective

'Cognitive deficits represent nuclear symptoms of schizophrenia and are considered prognostic factors of the disease. Moreover, they are resistant to the currently available treatments and it is clinically suspected that atypical antipsychotics might worsen cognitive conditions of schizophrenic patients. Preliminary data indicate the involvement of epigenetic regulation of histone deacetylases (HDACs) in this effect and the possibility of neuroinflammmatory activity as the inductor mechanism. In the etiopathogenesis of schizophrenia a double-hit phenomenon has been suggested. Thus, a prenatal priming event that would induce vulnerability is followed by a second stressful hit in peripuberty. Physio- and psychopathology could emerge from these mechanisms through neuroinflammatory hyperactivity. The aim of the present project is to study the relationship between cognitive deficits and neuroinflammatory activity in a traslational 'double hit' mouse model based on the maternal inmmune activation during gestation followed by social isolation at puberty. In this animal model will be evaluated: 1) Gene and protein expression of inflammatory signalling proteins, HDACs and the status of histone acetylation; 2) Cognitive and psychotic status by means of validated behavioural tests; 3) Modulation of cognitive responses by chronic treatment with the antipsychotic clozapine, the HDAC inhibitor SAHA and the inflammatory activity inhibitor minocycline. Cognitive responses will be related to neuroinflammatory alterations at molecular level. The findings in the animal model will be compared with those obtained in the study of neuroinflammation markers, HDACs expression and histone acetylation status in postmortem human prefrontal cortex of subjects with schizophrenia under antipsychotic treatment or drug-free conditions and matched controls. In these subjects the possibility of an excess of inflammatory activity associated to antipsychotic treatment will be analyzed.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SCHIZO-EPICOG" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SCHIZO-EPICOG" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

CREDit (2020)

Chronological REference Datasets and Sites (CREDit) towards improved accuracy and precision in luminescence-based chronologies

Read More  

DEF2DEV (2019)

Identification of the mode of action of plant defensins during root development and plant defense responses.

Read More  

EngPTC2 (2019)

Exploring new technologies for the next generation pulse tube cryocooler below 2K

Read More